Vyant Bio, Inc. Common Stock
VYNT
VYNT was delisted on the 12th of May, 2023.
10 hedge funds and large institutions have $1.26M invested in Vyant Bio, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
82% more capital invested
Capital invested by funds: $694K → $1.26M (+$568K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
17% less funds holding
Funds holding: 12 → 10 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$74.9K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$55.1K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.13K |
| 4 |
Morgan Stanley
New York
|
+$132 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$7.5K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.93K |
| 4 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
-$1K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$470 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $803K | +$74.9K | +3,980 | +11% |
|
|
MC
2
Mayo Clinic
Rochester,
Minnesota
| $184K | – | – | – |
|
3
BlackRock
New York
| $152K | – | – | – |
|
|
4
Acadian Asset Management
Boston,
Massachusetts
| $75K | +$55.1K | +2,928 | +436% |
|
5
Vanguard Group
Malvern,
Pennsylvania
| $44K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $2K | -$2.93K | -156 | -58% |
|
|
7
Osaic Holdings
Scottsdale,
Arizona
| $2K | +$1.13K | +60 | +222% |
|
|
8
Wells Fargo
San Francisco,
California
| – | -$7.5K | -399 | -99% |
|
|
9
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$3K | -185 | Closed |
|
|
10
Fifth Third Bancorp
Cincinnati,
Ohio
| – | -$1K | -40 | Closed |
|
|
11
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$470 | -25 | -71% |
|
|
12
Morgan Stanley
New York
| – | +$132 | +7 | New |
|
VYNT Hedge Fund Activity: Q3 2020 in Review
10 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Vyant Bio, Inc. Common Stock (VYNT) for Q3 2020, worth a combined $1.26M — up 82% from $694K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of VYNT and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Renaissance Technologies, adding an estimated $74.9K. The largest seller was Wells Fargo, cutting an estimated $7.5K.
- 10 institutional investors held Vyant Bio, Inc. Common Stock (VYNT) as of Q3 2020, down from 12 in Q2 2020.
- Funds reported $1.26M of Vyant Bio, Inc. Common Stock stock for Q3 2020, up 82% quarter-over-quarter.
- 1 fund opened new Vyant Bio, Inc. Common Stock positions in Q3 2020 and 3 closed out, a net change of -2 holders.
- The largest Vyant Bio, Inc. Common Stock buyer in Q3 2020 was Renaissance Technologies, an estimated $74.9K added.
- The largest Vyant Bio, Inc. Common Stock seller in Q3 2020 was Wells Fargo, an estimated $7.5K sold.
Based on aggregated 13F filings for Q3 2020.